Dermoscopic findings of perifollicular pigmentation associated with vandetanib

Dermatol Pract Concept. 2018 Oct 31;8(4):340-341. doi: 10.5826/dpc.0804a20. eCollection 2018 Oct.
No abstract available

Keywords: cutaneous adverse events; dermoscopy; pigmentation; tyrosine kinase inhibitor.